Our latest integrated analysis of genome, transcriptome and clinicopathological data has revealed that the non-aggressive group is further divided into the catenin beta-1 (CTNNB1)-mutated subtype and the metabolic disease-associated subtype, the latter of which is mainly composed of non-viral HCC8. This evidence concerns the gene CTNNB1 and metabolic disease.